Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms

The calamity of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), COVID-19, is still a global human tragedy. To date, no specific antiviral drug or therapy has been able to break the widespread of SARS-CoV2. It has been generally believed that stimulating protective immunity via...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayat, Maryam, Asemani, Yahya, Najafi, Sajad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049400/
https://www.ncbi.nlm.nih.gov/pubmed/33930707
http://dx.doi.org/10.1016/j.intimp.2021.107679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049400/
https://www.ncbi.nlm.nih.gov/pubmed/33930707
http://dx.doi.org/10.1016/j.intimp.2021.107679

Ejemplares similares